Segal Lloyd Mitchell (CIK 1477123) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-01-12). Recent activity: Buy AKTS (19,631 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-12 | Aktis Oncology, Inc. (AKTS) | Director | Buy | 19,631 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-01-12